Anna E. Martinez

Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders

Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response

Considerations in surgical management of a Buschke–Lowenstein tumor in Netherton syndrome: A case report

Severe persistent injection site reactions after subcutaneous 2′-O-methyl phosphorothioate oligonucleotide therapy for Duchenne muscular dystrophy